triggered tirzepatide | GLP-1R and GIPR ligand | Sterile Insights into the Mechanism of
Description
Never adjust your tirzepatide dose or discontinue treatment without medical guidance, as abrupt changes can affect glycemic control and weight management outcomes
In studies, people lost around 11 to 13% of their body weight
The combination approach appears most promising for long-term sustainability
[DOI] [PubMed] [Google Scholar] 18.Schulz C, Vezzani C, Kroemer NB
